Aripiprazole
Aripiprazole is a pharmaceutical drug with 242 clinical trials. Currently 1 active trials ongoing. Historical success rate of 86.0%.
Success Metrics
Based on 178 completed trials
Phase Distribution
Phase Distribution
16
Early Stage
24
Mid Stage
167
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.4%
178 of 216 finished
17.6%
38 ended early
1
trials recruiting
242
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Substance Misuse To Psychosis for Stimulants
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Aripiprazole in Body Focused Repetitive Behaviors
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
Clinical Trials (242)
Substance Misuse To Psychosis for Stimulants
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Aripiprazole in Body Focused Repetitive Behaviors
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression(SMART-I)
Biomarkers to Enhance Early Schizophrenia Treatment
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia
Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
Long-term Antipsychotic Pediatric Safety Trial
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 242